Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/PEP.0000000000000810 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Dexmedetomidine for Less Invasive Surfactant Administration: Another Promising Medicine in an Ever-Growing Toolbox?
Paediatr Drugs
January 2025
Department of Development and Regeneration, KU Leuven, Herestraat 49, 3000, Leuven, Belgium.
Commentary: Mixed Infection or Heteroresistance? Pediatric Tuberculosis Still the Achilles Heel of Diagnostic Tools.
Pediatr Infect Dis J
December 2024
From the Global Tuberculosis Program, Baylor College of Medicine, Houston, Texas.
Integrating Chronic Disease Management and Harm Reduction for Youth with Juvenile Idiopathic Arthritis Amid Canada's Overdose Crisis.
Children (Basel)
November 2024
Section of Rheumatology, Department of Paediatrics, Alberta Children's Hospital, Cumming School of Medicine, University of Calgary, 28 Oki Drive NW, Calgary, AB T3B 6A8, Canada.
Juvenile idiopathic arthritis (JIA) is a chronic autoimmune condition in children that often requires long-term pain management, which can include opioid use. In the context of Canada's ongoing overdose crisis, youth with JIA face risks due to potential opioid dependency and exposure to toxic drug supplies. This commentary proposes an integrated approach combining chronic disease management with harm reduction strategies specifically tailored for JIA patients.
View Article and Find Full Text PDFPolydeoxyribonucleotide Injection as an Alternative to Surgery in Hypoxic Conditions.
Int Neurourol J
December 2024
Unit of Pediatric Surgery, Department of Human Pathology of Adult and Childhood "Gaetano Barresi", University of Messina, Messina, Italy.
Amblyopia screening: the current state and opportunities for optimization.
Expert Rev Med Devices
January 2025
Division of Ophthalmology, Children's Hospital of Philadelphia.
Introduction: Amblyopia, the leading cause of monocular childhood vision loss, affects millions and is projected to increase. Early detection and treatment are crucial for preventing vision impairment.
Areas Covered: This commentary reviews the current state and opportunities for improvement in amblyopia screening strategy and technology focused primarily within the United States.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!